When is a Genotoxin not a Genotoxin? Richard Walmsley, University of Manchester, speaking at ADME & Predictive Toxicology Europe
miRNA Replacement Therapy in Cancer through Polyplex-Mediated miRNA Delivery In Vivo Professor Achim Aigner, Institute of Pharmacology / bpc, Philipps-University Marburg, speaking at RNAi Europe 2011.
EU Regulatory Landscape for Approval of Biosimilars Dr Lincoln Tsang, Arnold and Porter LLP, speaking at BioProcessing, Biologics & Biotherapeutics Congress / Stem Cells Europe 2011.
Biotests for Hazard Characterization of Waste Dr Reinhilde Weltens, Vito, speaking at Advances in Biosensors and Biodetection.
Drug Discovery Outsourcing: the Importance of Integration in the Selection of Higher Quality Clinical Candidates Simone Braggio, Director, Head of Drug Metabolism & Pharmacokinetics, Aptuit speaking at Pharma Outsourcing Congress 2011
Mode of Action Analysis and Biomarker Discovery Using Mass Spectrometry-Based Phosphoproteomics Technologies Andreas Jenne, CEO, Kinaxo, speaking at European Biomarkers Summit 2011.
Approach to Quick Lead Optimization Including Physicochemical and ADME Profiling Pranas Japertas, Director, ACD Labs, Speaking at Medchem Europe 2011.
Preclinical Drug Safety: High Quality Data obtained with a New Automated Patch Clamp Platform Olaf Scheel, CSO, Cytocentrics AG speaking at Pharma Outsourcing Congress 2011
In a Virtual World, Where Are the Walls of the House? The New Outsourcing Katya Tsaioun, President, Apredica speaking at Pharma Outsourcing Congress 2011